COVID-19, Stress Disorders, Post-Traumatic
Conditions
Brief summary
At the Métropole Savoie hospital, to deal with the daily influx of severe patients during the second wave of COVID-19, 23 patients had to be transferred away from their home city and far from their families as part of a medical evacuation (EVASAN). The purpose of the study is to investigate whether there is an association between medical evacuations and the occurrence of psychological disorders such as post-traumatic stress, anxiety or depression occurring within 6 to 10 months in families of evacuated patients. The investigators want to compare the prevalence of psychological disorders in the families of patients evacuated for a serious form of COVID-19 (cases) compared to that of families of patients not evacuated (controls) hospitalized for a serious form of COVID-19.
Detailed description
The case group is trusted person of evacuated patient. The control group is trusted person of not evacuated patient. The trusted person of the group control will be matched to trusted patient of the case group on : their relationship with the patient (spouse/ascendant/descendant/other) and on criteria specific to the patient: sex, age range ( \<75 years or ≥ 75 years), invasive ventilation and becoming at 3 months post COVID-19 (survivor / non survivor)
Interventions
to measure the affect of routine life stress,everyday traumas and acute stress
to measure anxiety and depression
SF-36 is a set of generic, coherent, and easily administered quality-of-life measures.
satisfaction survey of the trusted person about the communication with ICU personal
interview of the trusted person about the medical evacuation : evacuation announcement;organization of the medical evacuation,; concerns related to evacuations;reception and information by the center admitting the evacuated patient; arrangements of visit, patient repatriated
interview of the trusted person about ICU hospitalization: reception in ICU; ICU organization; concerns related to ICU hospitalization, information and communication with ICU staff, arrangements of visit, context of ICU discharge
Sponsors
Study design
Intervention model description
Case-Control Study
Eligibility
Inclusion criteria
Trusted person of patients admitted to the Adult Intensive Care Unit (ICU) of the Metropole Savoiehospital * during the second wave of COVID-19 in France * for a serious form of COVID-19 * hospitalized more than 72 hours in ICU the case group is trusted person of evacuated patient. the control group is trusted person of not evacuated patient. Non -inclusion criteria : Trusted Person Refusing patient Medical Evacuation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Comparison of the prevalence of post-traumatic stress disorder, among families of patients with severe COVID-19 evacuated to another region (case) compared to families of matched patients with severe COVID-19 not evacuated to another region (controls). | at 8months (+/-2 months) after medical evacuations for the case group, and at 8 months (+/-2 months) after ICU admission for the control group | the post-traumatic stress disorder of the trusted person is assessed by the Impact of Event Scale - Revised (IES-R), at 8months (+/-2 months) after medical evacuations for the case group, and at 8 months (+/-2 months) after Intensive Care Unit (ICU) admission for the control group |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of anxiety and/or depression symptoms questionnaire in families of patients hospitalized with severe COVID-19. | at 8 months (+/- 2months) in families of patients hospitalized in intensive care for a serious form of COVID-19. | Association between medical evacuations and the occurrence of symptoms of anxiety and/or depression at 8 months in families of patients hospitalized in intensive care for a serious form of COVID19. anxiety and/or depression symptoms assessed by the Hospital Anxiety and Depresion Scale (HADS) |
| Quality of Life in families of patients with severe COVID-19 | at 8 months (+/- 2months) in families of patients hospitalized in intensive care for a serious form of COVID-19. | Quality of Life assessed by Medical Outcomes Study Short Form 36 (SF-36) |
| Satisfaction with the communication between the health care team and the family of the patient hospitalized with severe form of COVID19 | at 8 months (+/- 2months) in families of patients hospitalized in intensive care for a serious form of COVID-19. | satisfaction is measured using a simple digital scale, |
| Qualitative analysis by a psychologist of a semi-structured interview of the testimony and specific experience of families at 8 months. | at 8 months (+/- 2months) in families of patients hospitalized in intensive care for a serious form of COVID-19. | semi-structured interview |
Countries
France